NCT06367257 App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
| NCT ID | NCT06367257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Erlangen-Nürnberg Medical School |
| Condition | Squamous Cell Carcinoma of Head and Neck |
| Study Type | INTERVENTIONAL |
| Enrollment | 148 participants |
| Start Date | 2024-02-29 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 148 participants in total. It began in 2024-02-29 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.
Eligibility Criteria
Inclusion Criteria: * Patients with squamous cell carcinoma in the head and neck region, who receive a postsurgical or definitive radio(chemo)therapy * Patients who have a smartphone on which the Emento app can be installed * Minimum age 18 years Exclusion Criteria: * Patients who are represented by a legal guardian * Patients who are not suitable for participation in the study due to a language barrier
Contact & Investigator
Marlen Haderlein, PD
STUDY DIRECTOR
Universitätsklinikum Erlangen, Radiation Oncology
Frequently Asked Questions
Who can join the NCT06367257 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Squamous Cell Carcinoma of Head and Neck. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06367257 currently recruiting?
Yes, NCT06367257 is actively recruiting participants. Contact the research team at studiensekretariat.ST@uk-erlangen.de for enrollment information.
Where is the NCT06367257 trial being conducted?
This trial is being conducted at Erlangen, Germany.
Who is sponsoring the NCT06367257 clinical trial?
NCT06367257 is sponsored by University of Erlangen-Nürnberg Medical School. The principal investigator is Marlen Haderlein, PD at Universitätsklinikum Erlangen, Radiation Oncology. The trial plans to enroll 148 participants.